Baseline characteristics of non-valvular atrial fibrillation (NVAF) patients taking NOAC, warfarin, and no-treatment before propensity score weighting.</p
<p>Values correspond to mean (SD) or number (%). BMI = body mass index; SBP = systolic blood pressur...
This study determined the association between co-morbidities, including heart failure (HF) and time ...
<p>*measure as mean ±SD or median (interquartile range).</p><p>NVAF denotes nonvalvular atrial fibri...
Baseline characteristics of non-valvular atrial fibrillation (NVAF) patients taking NOAC, warfarin, ...
Baseline characteristics of non-valvular atrial fibrillation (NVAF) patients who initiated apixaban,...
<p>Baseline characteristics of study patients with non-valvular atrial fibrillation<sup><a href="htt...
Baseline characteristics in the subjects (n = 1045) with and without atrial fibrillation (AF) in the...
<p>*<i>p</i><0.05</p><p>Baseline characteristics of the patients with no therapy, aspirin, and warfa...
AF: atrial fibrillation; NOAC: non-vitamin K antagonist oral anticoagulant; NVAF: non-valvular atria...
From January 1, 2000, to December 31, 2015, 5,197, 3,396, and 9,898 NVAF patients taking warfarin, n...
<p>Data are presented as n (%) or mean±SD. POAF, postoperative atrial fibrillation; BMI, body mass i...
<p>ACE: angiotensin-converting enzyme; ARB: angiotensin II receptor blocker; DCM: dilated cardiomyop...
Baseline characteristics for patients prescribed NSAIDs or acetaminophen with and without thrombotic...
Baseline characteristics that in the multivariate analysis significantly predicted new-onset atrial ...
The data report details the baseline characteristics and observed outcomes among patients included i...
<p>Values correspond to mean (SD) or number (%). BMI = body mass index; SBP = systolic blood pressur...
This study determined the association between co-morbidities, including heart failure (HF) and time ...
<p>*measure as mean ±SD or median (interquartile range).</p><p>NVAF denotes nonvalvular atrial fibri...
Baseline characteristics of non-valvular atrial fibrillation (NVAF) patients taking NOAC, warfarin, ...
Baseline characteristics of non-valvular atrial fibrillation (NVAF) patients who initiated apixaban,...
<p>Baseline characteristics of study patients with non-valvular atrial fibrillation<sup><a href="htt...
Baseline characteristics in the subjects (n = 1045) with and without atrial fibrillation (AF) in the...
<p>*<i>p</i><0.05</p><p>Baseline characteristics of the patients with no therapy, aspirin, and warfa...
AF: atrial fibrillation; NOAC: non-vitamin K antagonist oral anticoagulant; NVAF: non-valvular atria...
From January 1, 2000, to December 31, 2015, 5,197, 3,396, and 9,898 NVAF patients taking warfarin, n...
<p>Data are presented as n (%) or mean±SD. POAF, postoperative atrial fibrillation; BMI, body mass i...
<p>ACE: angiotensin-converting enzyme; ARB: angiotensin II receptor blocker; DCM: dilated cardiomyop...
Baseline characteristics for patients prescribed NSAIDs or acetaminophen with and without thrombotic...
Baseline characteristics that in the multivariate analysis significantly predicted new-onset atrial ...
The data report details the baseline characteristics and observed outcomes among patients included i...
<p>Values correspond to mean (SD) or number (%). BMI = body mass index; SBP = systolic blood pressur...
This study determined the association between co-morbidities, including heart failure (HF) and time ...
<p>*measure as mean ±SD or median (interquartile range).</p><p>NVAF denotes nonvalvular atrial fibri...